Timolol is a nonselective beta-adrenergic antagonist given in an eye drop solution to reduce intraocular pressure, or pressure in the eyes.[L6724] It is also used in tablet form as a drug to treat hypertension.[L6727] Timolol was first approved by the FDA in 1978.[L6724] This drug is marketed by several manufacturers [L6736] and is an effective agent for the management of conditions such as open-angle glaucoma and hypertension.
Timolol Maleate Ophthalmic Gel Forming Solution 0.5%
Apo-dorzo-timop
Timolol maleate
Timolol-5 Tab 5mg
T-LO
Dorzolamide Hydrochloride-Timolol Maleate
Sandoz Brimonidine / Timolol
Apo-latanoprost-timop
Timolol Maleate
Timolol-10 Tab 10mg
Dorzolamide HCl and Timolol Maleate
Timolol
Dorzolamide hydrochloride and timolol maleate
Apo-travoprost-timolol Pq
Sandoz Travoprost / Timolol Pq
Dorzolamide-timolol PF
Indication
Ophthalmic timolol is indicated for the treatment of increased intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The oral form of this drug is used to treat high blood pressure.[L6724,L6727] In certain cases, timolol is used in the prevention of migraine headaches.[A179530,L6742]
Categories
Adrenergic Antagonists
Adrenergic beta-Antagonists
Agents causing hyperkalemia
Alcohols
Amines
Amino Alcohols
Antiarrhythmic agents
Antiglaucoma Preparations and Miotics
Antihypertensive Agents
Beta Blocking Agents and Thiazides
Beta Blocking Agents, Non-Selective
Beta Blocking Agents, Non-Selective, and Thiazides
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682